Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants

NCT07726914 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Graft Versus Host Disease

Interventions

DRUG: Belumosudil
DRUG: Belumosudil

Sponsor

Sanofi